This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1981 Jul;36(1):1-18.

doi: 10.1016/0009-2797(81)90025-9.

The interaction of nogalamycin and analogs with DNA and other biopolymers

W C Krueger, L M Pschigoda, S L Schpok, A Moscowitz, J P McGovren, P Neta, M V Merritt, L H Li

PMID: 7249146
DOI: 10.1016/0009-2797(81)90025-9

The interaction of nogalamycin and analogs with DNA and other biopolymers

W C Krueger et al. Chem Biol Interact. 1981 Jul.

. 1981 Jul;36(1):1-18.

doi: 10.1016/0009-2797(81)90025-9.

Authors

W C Krueger, L M Pschigoda, S L Schpok, A Moscowitz, J P McGovren, P Neta, M V Merritt, L H Li

PMID: 7249146
DOI: 10.1016/0009-2797(81)90025-9

No abstract available

PubMed Disclaimer

Similar articles

Evidence of different binding sites for nogalamycin in DNA revealed by association kinetics.
Fox KR, Waring MJ. Fox KR, et al. Biochim Biophys Acta. 1984 Nov 28;802(2):162-8. doi: 10.1016/0304-4165(84)90157-0. Biochim Biophys Acta. 1984. PMID: 6498212
Kinetics of dissociation of nogalamycin from DNA: comparison with other anthracycline antibiotics.
Fox KR, Brassett C, Waring MJ. Fox KR, et al. Biochim Biophys Acta. 1985 Jul 5;840(3):383-92. doi: 10.1016/0304-4165(85)90219-3. Biochim Biophys Acta. 1985. PMID: 3859336
Template specificity of DNA binding by nogalamycin and its analogs utilizing competitive fluorescence polarization.
Richardson CL, Grant AD, Schpok SL, Krueger WC, Li LH. Richardson CL, et al. Cancer Res. 1981 Jun;41(6):2235-40. Cancer Res. 1981. PMID: 7237423
Anthracycline analogs: the past, present, and future.
Weiss RB, Sarosy G, Clagett-Carr K, Russo M, Leyland-Jones B. Weiss RB, et al. Cancer Chemother Pharmacol. 1986;18(3):185-97. doi: 10.1007/BF00273384. Cancer Chemother Pharmacol. 1986. PMID: 2948729 Review. No abstract available.
The biochemical pharmacology of nogalamycin and its derivatives.
Li LH, Krueger WC. Li LH, et al. Pharmacol Ther. 1991;51(2):239-55. doi: 10.1016/0163-7258(91)90080-6. Pharmacol Ther. 1991. PMID: 1838416 Review.

See all similar articles

Cited by

Evaluation of menogaril in renal cell carcinoma. A Southwest Oncology Group phase II study (8504).
Stephens RL, Goodman P, Crawford ED, Spicer CF, Lowe BA, Ahmann FR, Chapman R, Natale RB. Stephens RL, et al. Invest New Drugs. 1990;8 Suppl 1:S69-71. Invest New Drugs. 1990. PMID: 2143177
Phase I clinical and pharmacokinetic study of menogaril (7-con-O-methylnogarol) in previously treated patients with acute leukemia.
Mazurek C, Dutcher JP, Schwartz EL, Garl S, Benson L, Wiernik PH. Mazurek C, et al. Invest New Drugs. 1993 Nov;11(4):313-22. doi: 10.1007/BF00874430. Invest New Drugs. 1993. PMID: 8157473 Clinical Trial.
Phase II evaluation of menogaril (NSC-269148) in non-small cell lung carcinoma. A Southwest Oncology Group study.
Vance RB, Crowley JJ, Macdonald JS, Ahmann FR. Vance RB, et al. Invest New Drugs. 1991 Feb;9(1):73-5. doi: 10.1007/BF00194549. Invest New Drugs. 1991. PMID: 1851143 Clinical Trial.
A phase I clinical and pharmacokinetic study of the oral and the oral/intravenous administration of menogaril.
Weiss GR, Brown TD, Kuhn JG, Von Hoff DD, Earhart RH, Adams WJ, Brewer JE, Hosley JD, Kasunic DA. Weiss GR, et al. Invest New Drugs. 1993 Feb;11(1):17-27. doi: 10.1007/BF00873906. Invest New Drugs. 1993. PMID: 8349432 Clinical Trial.
Menogaril, an anthracycline derivative, inhibits DNA topoisomerase II by stabilizing cleavable complexes.
Ono K, Ikegami Y, Nishizawa M, Andoh T. Ono K, et al. Jpn J Cancer Res. 1992 Sep;83(9):1018-23. doi: 10.1111/j.1349-7006.1992.tb02016.x. Jpn J Cancer Res. 1992. PMID: 1331004 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science